Evidence map›Paper›PMID 34415218›Full record

ArticleJournal of biomolecular structure & dynamics2022

Vitamin D3 and its hydroxyderivatives as promising drugs against COVID-19: a computational study.

Yuwei Song, Shariq Qayyum, Rory A Greer, Radomir M Slominski, Chander Raman, Andrzej T Slominski, Yuhua Song

Open access · greenAbstract read
In one paragraph

Article in Journal of biomolecular structure & dynamics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Evolutionary formation of melatonin and vitamin D in early life forms: insects take centre stage.Biological reviews of the Cambridge Philosophical Society · 2024
    Review
  5. Article
  6. Vitamin D and COVID-19: where are we now?Postgraduate medicine · 2023
    Review
  7. Article
  8. Review
  9. Vitamin D-A prominent immunomodulator to prevent COVID-19 infection.International journal of rheumatic diseases · 2023
    Review
  10. Review
  11. Vitamin D Signaling in Psoriasis: Pathogenesis and Therapy.International journal of molecular sciences · 2022
    Review
  12. The Role of Vitamin D in Supporting Health in the COVID-19 Era.International journal of molecular sciences · 2022
    Review
  13. Article
  14. Article
  15. Review
  16. Vitamin D and COVID-19: An Overview of Recent Evidence.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuwei SongDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Shariq QayyumDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Rory A GreerDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, USA.
Radomir M SlominskiDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Chander RamanDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Andrzej T SlominskiDepartment of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA.
Yuhua SongDepartment of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-2583-850X
University of Alabama at Birmingham · US

Funding

Mechanism of action and function of novel secosteroid 20(OH)D3 in the skinR01AR073004 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ANDRZEJ T SLOMINSKI · 2018 to 2026
$2.9M
Novel Biosynthetic Pathway for Secosteroids and the SkinR01AR052190 · NIAMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI POSTLETHWAITE, ARNOLD E, SLOMINSKI, ANDRZEJ T · 2006 to 2013
$2.2M
Significance of metabolic activation of lumisterol in the skinR01AR071189 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SLOMINSKI, ANDRZEJ T · 2017 to 2021
$1.6M
Development and Functional Assessment of Cardiovascular Tissue Engineering Therapy (CVTE) T32 Training GrantT32EB023872 · NIBIB · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROGERS, JACK M, ZHANG, JIANYI · 2018 to 2022
$753k
Canonical and non-canonical vitamin D activation pathways in systemic lupusR21AI149267 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI RAMAN, CHANDER, SLOMINSKI, ANDRZEJ T · 2020 to 2021
$408k
CYP11A1-derived secosteroids as therapeutic agents in UVB induced skin cancerI01BX004293 · VA · BIRMINGHAM VA MEDICAL CENTER · PI SLOMINSKI, ANDRZEJ T · 2019 to 2025
–
BLRD VA I01 BX004293NIAID NIH HHS R21 AI149267NIAMS NIH HHS R01 AR052190NIAMS NIH HHS R01 AR071189NIAMS NIH HHS R01 AR073004NIBIB NIH HHS T32 EB023872
6 · The paper itself

Abstract

The epidemiologic correlation between the poor prognosis of SARS-CoV-2 infection and vitamin D deficiency has been observed worldwide, however, their molecular mechanisms are not fully understood. In this study, we used combined molecular docking, molecular dynamics simulations and binding free energy analyses to investigate the potentials of vitamin D3 and its hydroxyderivatives as TMPRSS2 inhibitor and to inhibit the SARS-CoV-2 receptor binding domain (RBD) binding to angiotensin-converting enzyme 2 (ACE2), as well as to unveil molecular and structural basis of 1,25(OH)

Indexed as

COVID-19Angiotensin-Converting Enzyme 2CholecalciferolHumansMolecular Docking SimulationMolecular Dynamics SimulationProtein BindingRNA, ViralSARS-CoV-2Angiotensin-Converting Enzyme 2CholecalciferolRNA, ViralACE2binding free energy analysisCOVID-19molecular dockingmolecular dynamics simulationSARS-CoV-2 RBDTMPRSS2vitamin D3 and its hydroxyderivatives

Identifiers

PMID34415218
PMCPMC8858339
OpenAlexW3194437937

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.